AKTX vs RHHBF: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Side-by-side fundamentals for Akari Therapeutics Plc (AKTX) and Roche Holding AG (RHHBF) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | AKTX | RHHBF |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - General |
| Current Price (Cboe, delayed) | $9.01 | $433 |
| Market Cap | $1.40T | $372.09B |
| PE Ratio | — | 15.91 |
| PEG Ratio | — | — |
| PEG Verdict | N/A | N/A |